US2016074327A1PendingUtilityA1

Process for preparing microparticles

Assignee: CRITICAL PHARMACEUTICALS LTDPriority: Jul 11, 2008Filed: Nov 20, 2015Published: Mar 17, 2016
Est. expiryJul 11, 2028(~2 yrs left)· nominal 20-yr term from priority
A61P 7/00A61P 25/18A61K 31/519A61K 9/1647A61K 9/145A61K 9/1694A61K 9/146A61K 9/1682A61K 38/385A61K 47/14A61K 9/16A61K 47/30
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A process for preparing microparticles comprising a biologically active material and a polymer and having a mean particle size expressed as the volume mean diameter (VMD) of from 10 to 500 μm, wherein the biologically active material is substantially insoluble in the polymer, which process comprises: a. contacting a mixture of the biologically active material or a precursor thereof, the polymer or a precursor thereof and a processing aid with a supercritical fluid which is capable of swelling the polymer under temperature and pressure conditions necessary to maintain the fluid in a supercritical state; b. allowing the supercritical fluid to penetrate and liquefy the polymer, whilst maintaining the temperature and pressure conditions so that the fluid is maintained in a supercritical state; c. releasing the pressure to precipitate microparticles comprising the biologically active agent and the polymer.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 . A process for preparing microparticles comprising a biologically active material and a polymer, said microparticles having a mean particle size expressed as the volume mean diameter (VMD) of from 10 to 500 μm, wherein the biologically active material is substantially insoluble in the polymer, which process comprises:
 a. contacting a mixture of the biologically active material or a precursor thereof, the polymer or a precursor thereof and a processing aid with a supercritical fluid which is capable of swelling the polymer under temperature and pressure conditions necessary to maintain the fluid in a supercritical state; 
 b. allowing the supercritical fluid to penetrate and liquefy the polymer, whilst maintaining the temperature and pressure conditions so that the fluid is maintained in a supercritical state; and 
 c. releasing the pressure to precipitate microparticles comprising the biologically active agent and the polymer.

Join the waitlist — get patent alerts

Track US2016074327A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.